KidneyDiet

Try out a kidney diet for a week with us! An initiative by a group of nephrologists to improve the kidney diet education amongst healthcare workers.

[KidneyDiet @DietKidney]

Have you ever recommended a kidney diet? If yes, fo you know how this diet might change your patients lifestyle? We are offering an amazing opportunity to try out an individualized kidney diet with us for a week.
To sign up; fill out our survey here:
https://t.co/gUAFMPIDpL

[Sayna Norouzi, MD, FASN @SaynaNorouzi]

Our PKD Medical Directorship Program had a fantastic year ❤️amazing feedback, real impact. Now we’re calling for our next cohort!

If you’re passionate about making a difference in #PKD care, we’d love to have you join us. Apply today 👇 @GlomCon

https://t.co/LnUR3STymJ

@fouadchebib @pranavgarimella @ndahl48

[ASN Publications @asnpublications]

In older adults on hemodialysis, deprescribing was feasible and generally well tolerated, with no serious withdrawal-related events. Patients viewed discussions positively, though better workflow integration and communication are needed, according to study in #ASNKidney30. https://t.co/4YXUJL52gg

[AJKD @AJKDonline]

Steroid Minimization in Kidney Transplantation: Rationale, Implementation, and Future Directions

https://t.co/hypBYyQYY7

@wisit661 @yasar_caliskan @KristaLentine

[ASN Publications @asnpublications]

CKD is common in pulmonary hypertension. In >9,000 patients, worse hemodynamics, including higher right atrial pressure and pulmonary vascular resistance and lower cardiac index, were associated with worse kidney function and predicted incident CKD. https://t.co/pyuSMVnAvU #ASNKidney360

[GlomCon @GlomCon]

🎓 Honoring the PKD-MDP Class of 2026

Join us on Tuesday, August 25th, as we celebrate the accomplishments of the 2026 class of the Polycystic Kidney Disease Medical Directorship Program (PKD-MDP)!

We’re proud to recognize the dedication, leadership, and growth of this exceptional cohort and celebrate all they have accomplished throughout their journey.

#PKDMDP #PolycysticKidneyDisease #PKD #Nephrology #MedicalEducation #ClassOf2026

[Dr. Hardik Patel 🩺💉 @hardik4u24]

🧠 Obesity-related kidney injury needs phenotype-based treatment—not a one-size-fits-all approach

⚖️ Weight loss + lifestyle
💊 GLP-1RA | SGLT2i | ACEi/ARB | nsMRA
🫀 Target kidney + CV risk together
🔄 Reassess every 3–6 months

🔗 https://t.co/gE7YOGOO2w

[Mayo Clinic Nephrology @MayoClinicNeph]

A multi-center cohort study evaluated hemoglobinuria as a marker of inflammation in IgA nephropathy

@mvargas07 @AnilaCara @fervenzaf @LadanZand @GlassockJ @andreaangioi @SethiRenalPath

https://t.co/bdyINY3642

[Sayna Norouzi, MD, FASN @SaynaNorouzi]

Such an exciting milestone. ✨⭐️
Grateful for a fantastic first cohort of fellows, the leadership team and faculty who made it happen.
#PKDMDP @fouadchebib @pranavgarimella @ndahl48 ✨⭐️

[AJKD @AJKDonline]

NEW Commentary by Zohreh Gholizadeh Ghozloujeh & @SaynaNorouzi on the #AJKDBlog:

After Remission, What Next? Rethinking Rituximab Strategy in Idiopathic Nephrotic Syndrome

https://t.co/EyrUjQVKC1

[Sayna Norouzi, MD, FASN @SaynaNorouzi]

Had a great time talking lupus nephritis on this podcast 🎙️

Grew out of our new #KDOQI commentary. Know the data and guidelines, but treat the patient in front of you.🫶
@osamaelshamy88 @AJKDonline @NKF_NephPros Thank you for the invite ⭐️
https://t.co/oJuKm6s9Dr

#RareKidneyDisease #Lupus #LupusNephritis

[Sayna Norouzi, MD, FASN @SaynaNorouzi]

#Obesity is a major challenge in #kidneydisease care and the management is changing.

We’re suggesting mechanism-based risk stratification over one-size-fits-all treatment.
Thank you @NDTsocial for the opportunity. 🙌🏻
@AKronbichler @edgarvlermamd @GivHeidariMD ✨⭐️

https://t.co/TCfh9M7plh

[ASN Publications @asnpublications]

Is it time for clinicians to rethink “fistula first” for every older dialysis patient? The best access may be the one that aligns with the patient’s health, priorities, and quality of life, according to new research published in #ASNJASN. https://t.co/KFYQaSZtUj

[Laurent ARNAUD @Lupusreference]

✅ The revised #SDI #lupus #damage index has also been published in @Lupus_SM
OPENACCESS at: https://t.co/TXFSjBITwp

[Sayna Norouzi, MD, FASN @SaynaNorouzi]

🔥A new French cohort study (Laslandes et al., 134 adults with MCD (66.4 %)/FSGS) found that maintenance rituximab dosing between 6 to 12 months post-induction cut relapse risk substantially with no clear increase in severe infections.

🚨Our take: this is direction-setting, not practice-changing. It challenges a purely reactive, relapse-only approach; but not sure if it can justify routine fixed-interval maintenance for everyone. The future is individualized, risk-adapted retreatment, not calendar-based fixed dosing.

Thanks to @AJKDonline for the chance to share our thoughts.

#Nephrology #Rituximab #FSGS #NephroticSyndrome #RareKidneyDisease #MCD #Kidneys

[Ladan Zand @LadanZand]

Congratulations @SaynaNorouzi & @poyanmehr for organizing such an amazing meeting and brining together so many of us who love GN! It was wonderful to connect, share and celebrate our passion for GN and most importantly work together to move the needle forward for our patients ❤️

[Sayna Norouzi, MD, FASN @SaynaNorouzi]

Huge thanks to all the faculty and participants who brought their expertise and heart to #GlomConHawaii! What an incredible community. Let’s keep being bold; better outcomes for our patients start with moments like this. 🙌
#RareKidneyDisease #Nephrology
@GlomCon

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

Thank you for another opportunity to be part of @GlomCon @poyanmehr @SaynaNorouzi @d_r_waguespack @erin_vaughan_ @BetterCallSeeth @nephrologista @VladoPerkovic @JeanHouMD

#GlomConHawaii 🌊

[Sayna Norouzi, MD, FASN @SaynaNorouzi]

eGFR data in patients with glomerular diseases #FINDCKD #GlomConHawaii @VladoPerkovic @GlomCon 🔥🙌🏻

[Sayna Norouzi, MD, FASN @SaynaNorouzi]

Popular scientific interviews by @brendonneuen @GlomCon #GlomConHawaii

[Ladan Zand @LadanZand]

It was an amazing lecture! Congratulations Sanjeev!